Shanghai Junshi Biosciences Co., Ltd. (HKG:1877)

Market Cap	36.33B
Revenue (ttm)	2.71B
Net Income (ttm)	-1.04B
Shares Out	1.03B
EPS (ttm)	-1.05
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,001,800
Average Volume	2,974,321
Open	23.08
Previous Close	23.28
Day's Range	23.04 - 23.50
52-Week Range	10.32 - 38.64
Beta	0.75
RSI	46.22
Earnings Date	Mar 14, 2026

About HKG:1877

Shanghai Junshi Biosciences Co., Ltd., a biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in the therapeutic areas of malignant tumors, neurological, autoimmune, chronic metabolic, nervous system, and infectious diseases in the People's Republic of China. The company was founded in 2012 and is headquartered in Shanghai, People's Republic of China.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2012
• Employees: 2,578
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1877

Financial Performance

In 2024, HKG:1877's revenue was 1.95 billion, an increase of 29.67% compared to the previous year's 1.50 billion. Losses were -1.28 billion, -43.90% less than in 2023.

Financial numbers in CNY